nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxandrolone—Testicular atrophy—Carbamazepine—epilepsy syndrome	0.0465	0.0566	CcSEcCtD
Oxandrolone—Virilism—Pregabalin—epilepsy syndrome	0.0407	0.0495	CcSEcCtD
Oxandrolone—Glucose tolerance decreased—Pregabalin—epilepsy syndrome	0.0234	0.0284	CcSEcCtD
Oxandrolone—Epididymitis—Lamotrigine—epilepsy syndrome	0.0222	0.027	CcSEcCtD
Oxandrolone—Hepatic necrosis—Acetazolamide—epilepsy syndrome	0.0161	0.0196	CcSEcCtD
Oxandrolone—Epididymitis—Pregabalin—epilepsy syndrome	0.0159	0.0194	CcSEcCtD
Oxandrolone—Necrosis—Phenobarbital—epilepsy syndrome	0.015	0.0182	CcSEcCtD
Oxandrolone—Epididymitis—Gabapentin—epilepsy syndrome	0.0146	0.0178	CcSEcCtD
Oxandrolone—Priapism—Oxcarbazepine—epilepsy syndrome	0.0146	0.0177	CcSEcCtD
Oxandrolone—Acne—Rufinamide—epilepsy syndrome	0.0137	0.0167	CcSEcCtD
Oxandrolone—Menstruation irregular—Clonazepam—epilepsy syndrome	0.0129	0.0156	CcSEcCtD
Oxandrolone—Hirsutism—Zonisamide—epilepsy syndrome	0.0127	0.0155	CcSEcCtD
Oxandrolone—Hirsutism—Clonazepam—epilepsy syndrome	0.0122	0.0149	CcSEcCtD
Oxandrolone—Hirsutism—Phenytoin—epilepsy syndrome	0.0122	0.0148	CcSEcCtD
Oxandrolone—Hirsutism—Carbamazepine—epilepsy syndrome	0.0116	0.0141	CcSEcCtD
Oxandrolone—Hirsutism—Lamotrigine—epilepsy syndrome	0.0112	0.0137	CcSEcCtD
Oxandrolone—Jaundice cholestatic—Acetazolamide—epilepsy syndrome	0.0107	0.013	CcSEcCtD
Oxandrolone—Necrosis—Felbamate—epilepsy syndrome	0.00961	0.0117	CcSEcCtD
Oxandrolone—Acne—Vigabatrin—epilepsy syndrome	0.00941	0.0115	CcSEcCtD
Oxandrolone—Menstruation irregular—Valproic Acid—epilepsy syndrome	0.00936	0.0114	CcSEcCtD
Oxandrolone—Irritability—Trimethadione—epilepsy syndrome	0.0092	0.0112	CcSEcCtD
Oxandrolone—Creatinine increased—Propofol—epilepsy syndrome	0.00915	0.0111	CcSEcCtD
Oxandrolone—Necrosis—Phenytoin—epilepsy syndrome	0.00901	0.011	CcSEcCtD
Oxandrolone—Acne—Felbamate—epilepsy syndrome	0.00897	0.0109	CcSEcCtD
Oxandrolone—Jaundice cholestatic—Zonisamide—epilepsy syndrome	0.00841	0.0102	CcSEcCtD
Oxandrolone—Acne—Oxcarbazepine—epilepsy syndrome	0.00836	0.0102	CcSEcCtD
Oxandrolone—Irritability—Phenobarbital—epilepsy syndrome	0.00815	0.00992	CcSEcCtD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—SNIP1—epilepsy syndrome	0.00811	0.0533	CbGpPWpGaD
Oxandrolone—Hirsutism—Pregabalin—epilepsy syndrome	0.00806	0.00981	CcSEcCtD
Oxandrolone—Acne—Lamotrigine—epilepsy syndrome	0.00775	0.00943	CcSEcCtD
Oxandrolone—Fluid retention—Fosphenytoin—epilepsy syndrome	0.00771	0.00939	CcSEcCtD
Oxandrolone—Irritability—Lacosamide—epilepsy syndrome	0.00751	0.00914	CcSEcCtD
Oxandrolone—Hirsutism—Gabapentin—epilepsy syndrome	0.00739	0.009	CcSEcCtD
Oxandrolone—Irritability—Clobazam—epilepsy syndrome	0.00729	0.00887	CcSEcCtD
Oxandrolone—AR—Notch-mediated HES/HEY network—ASCL1—epilepsy syndrome	0.0072	0.0473	CbGpPWpGaD
Oxandrolone—Gynaecomastia—Diazepam—epilepsy syndrome	0.00698	0.00849	CcSEcCtD
Oxandrolone—Neoplasm—Felbamate—epilepsy syndrome	0.00682	0.0083	CcSEcCtD
Oxandrolone—Fluid retention—Phenytoin—epilepsy syndrome	0.00671	0.00817	CcSEcCtD
Oxandrolone—Haemoglobin—Trimethadione—epilepsy syndrome	0.00671	0.00816	CcSEcCtD
Oxandrolone—Fluid retention—Oxcarbazepine—epilepsy syndrome	0.00668	0.00813	CcSEcCtD
Oxandrolone—Haemorrhage—Trimethadione—epilepsy syndrome	0.00667	0.00812	CcSEcCtD
Oxandrolone—Gynaecomastia—Zonisamide—epilepsy syndrome	0.00661	0.00804	CcSEcCtD
Oxandrolone—Necrosis—Valproic Acid—epilepsy syndrome	0.0066	0.00804	CcSEcCtD
Oxandrolone—Irritability—Acetazolamide—epilepsy syndrome	0.0065	0.00791	CcSEcCtD
Oxandrolone—Fluid retention—Carbamazepine—epilepsy syndrome	0.00641	0.0078	CcSEcCtD
Oxandrolone—Gynaecomastia—Clonazepam—epilepsy syndrome	0.00637	0.00775	CcSEcCtD
Oxandrolone—Gynaecomastia—Phenytoin—epilepsy syndrome	0.00633	0.0077	CcSEcCtD
Oxandrolone—AR—Nongenotropic Androgen signaling—GNAO1—epilepsy syndrome	0.00618	0.0406	CbGpPWpGaD
Oxandrolone—Gynaecomastia—Carbamazepine—epilepsy syndrome	0.00604	0.00735	CcSEcCtD
Oxandrolone—Blood creatinine increased—Propofol—epilepsy syndrome	0.00593	0.00721	CcSEcCtD
Oxandrolone—Irritability—Midazolam—epilepsy syndrome	0.00591	0.00719	CcSEcCtD
Oxandrolone—Irritability—Levetiracetam—epilepsy syndrome	0.00583	0.0071	CcSEcCtD
Oxandrolone—Irritability—Vigabatrin—epilepsy syndrome	0.00549	0.00668	CcSEcCtD
Oxandrolone—Jaundice cholestatic—Pregabalin—epilepsy syndrome	0.00533	0.00649	CcSEcCtD
Oxandrolone—Irritability—Zonisamide—epilepsy syndrome	0.00512	0.00623	CcSEcCtD
Oxandrolone—Acne—Gabapentin—epilepsy syndrome	0.00511	0.00621	CcSEcCtD
Oxandrolone—Blood creatinine increased—Zonisamide—epilepsy syndrome	0.00502	0.00611	CcSEcCtD
Oxandrolone—Irritability—Clonazepam—epilepsy syndrome	0.00493	0.006	CcSEcCtD
Oxandrolone—Creatinine increased—Pregabalin—epilepsy syndrome	0.00492	0.00599	CcSEcCtD
Oxandrolone—Irritability—Phenytoin—epilepsy syndrome	0.0049	0.00596	CcSEcCtD
Oxandrolone—Irritability—Oxcarbazepine—epilepsy syndrome	0.00487	0.00593	CcSEcCtD
Oxandrolone—AR—SIDS Susceptibility Pathways—SNTA1—epilepsy syndrome	0.0048	0.0315	CbGpPWpGaD
Oxandrolone—Neoplasm—Valproic Acid—epilepsy syndrome	0.00469	0.0057	CcSEcCtD
Oxandrolone—Irritability—Carbamazepine—epilepsy syndrome	0.00468	0.00569	CcSEcCtD
Oxandrolone—Erectile dysfunction—Vigabatrin—epilepsy syndrome	0.00458	0.00557	CcSEcCtD
Oxandrolone—Irritability—Lamotrigine—epilepsy syndrome	0.00452	0.0055	CcSEcCtD
Oxandrolone—Creatinine increased—Gabapentin—epilepsy syndrome	0.00451	0.00549	CcSEcCtD
Oxandrolone—Erectile dysfunction—Diazepam—epilepsy syndrome	0.00451	0.00548	CcSEcCtD
Oxandrolone—Fluid retention—Pregabalin—epilepsy syndrome	0.00445	0.00541	CcSEcCtD
Oxandrolone—Haemoglobin—Propofol—epilepsy syndrome	0.0044	0.00535	CcSEcCtD
Oxandrolone—Haemorrhage—Propofol—epilepsy syndrome	0.00438	0.00532	CcSEcCtD
Oxandrolone—Acne—Topiramate—epilepsy syndrome	0.0043	0.00523	CcSEcCtD
Oxandrolone—Insomnia—Trimethadione—epilepsy syndrome	0.00429	0.00522	CcSEcCtD
Oxandrolone—Erectile dysfunction—Zonisamide—epilepsy syndrome	0.00427	0.00519	CcSEcCtD
Oxandrolone—Neoplasm—Pregabalin—epilepsy syndrome	0.00424	0.00516	CcSEcCtD
Oxandrolone—Gynaecomastia—Pregabalin—epilepsy syndrome	0.00419	0.0051	CcSEcCtD
Oxandrolone—Erectile dysfunction—Clonazepam—epilepsy syndrome	0.00411	0.00501	CcSEcCtD
Oxandrolone—Fluid retention—Gabapentin—epilepsy syndrome	0.00408	0.00496	CcSEcCtD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CACNA1G—epilepsy syndrome	0.004	0.0263	CbGpPWpGaD
Oxandrolone—Danazol—CCL2—epilepsy syndrome	0.00395	0.153	CrCbGaD
Oxandrolone—Erectile dysfunction—Carbamazepine—epilepsy syndrome	0.0039	0.00475	CcSEcCtD
Oxandrolone—Gynaecomastia—Gabapentin—epilepsy syndrome	0.00384	0.00468	CcSEcCtD
Oxandrolone—Haemoglobin—Felbamate—epilepsy syndrome	0.00381	0.00463	CcSEcCtD
Oxandrolone—Creatinine increased—Topiramate—epilepsy syndrome	0.0038	0.00462	CcSEcCtD
Oxandrolone—Haemorrhage—Felbamate—epilepsy syndrome	0.00379	0.00461	CcSEcCtD
Oxandrolone—Erectile dysfunction—Lamotrigine—epilepsy syndrome	0.00377	0.00459	CcSEcCtD
Oxandrolone—Insomnia—Rufinamide—epilepsy syndrome	0.00373	0.00453	CcSEcCtD
Oxandrolone—AR—Coregulation of Androgen receptor activity—UBE3A—epilepsy syndrome	0.00359	0.0236	CbGpPWpGaD
Oxandrolone—Haemoglobin—Clonazepam—epilepsy syndrome	0.00359	0.00437	CcSEcCtD
Oxandrolone—Haemorrhage—Clonazepam—epilepsy syndrome	0.00357	0.00435	CcSEcCtD
Oxandrolone—Haemoglobin—Phenytoin—epilepsy syndrome	0.00357	0.00434	CcSEcCtD
Oxandrolone—Haemorrhage—Phenytoin—epilepsy syndrome	0.00355	0.00432	CcSEcCtD
Oxandrolone—Spironolactone—SLCO1A2—epilepsy syndrome	0.00352	0.136	CrCbGaD
Oxandrolone—AR—Nongenotropic Androgen signaling—PLCB1—epilepsy syndrome	0.00351	0.023	CbGpPWpGaD
Oxandrolone—Insomnia—Lacosamide—epilepsy syndrome	0.0035	0.00426	CcSEcCtD
Oxandrolone—Fluid retention—Topiramate—epilepsy syndrome	0.00343	0.00418	CcSEcCtD
Oxandrolone—Insomnia—Clobazam—epilepsy syndrome	0.0034	0.00413	CcSEcCtD
Oxandrolone—Haemoglobin—Lamotrigine—epilepsy syndrome	0.00329	0.00401	CcSEcCtD
Oxandrolone—Haemorrhage—Lamotrigine—epilepsy syndrome	0.00328	0.00399	CcSEcCtD
Oxandrolone—Neoplasm—Topiramate—epilepsy syndrome	0.00327	0.00398	CcSEcCtD
Oxandrolone—Irritability—Pregabalin—epilepsy syndrome	0.00325	0.00395	CcSEcCtD
Oxandrolone—Blood creatinine increased—Pregabalin—epilepsy syndrome	0.00319	0.00388	CcSEcCtD
Oxandrolone—Oedema—Propofol—epilepsy syndrome	0.00311	0.00378	CcSEcCtD
Oxandrolone—Methyltestosterone—SLCO1A2—epilepsy syndrome	0.0031	0.12	CrCbGaD
Oxandrolone—AR—Coregulation of Androgen receptor activity—TCF4—epilepsy syndrome	0.00301	0.0198	CbGpPWpGaD
Oxandrolone—AR—Nongenotropic Androgen signaling—CDC42—epilepsy syndrome	0.00299	0.0196	CbGpPWpGaD
Oxandrolone—Irritability—Gabapentin—epilepsy syndrome	0.00298	0.00362	CcSEcCtD
Oxandrolone—Blood creatinine increased—Gabapentin—epilepsy syndrome	0.00292	0.00356	CcSEcCtD
Oxandrolone—Oedema—Vigabatrin—epilepsy syndrome	0.00283	0.00344	CcSEcCtD
Oxandrolone—Insomnia—Propofol—epilepsy syndrome	0.00281	0.00342	CcSEcCtD
Oxandrolone—AR—SIDS Susceptibility Pathways—MECP2—epilepsy syndrome	0.00276	0.0181	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—ASCL1—epilepsy syndrome	0.00276	0.0181	CbGpPWpGaD
Oxandrolone—Insomnia—Levetiracetam—epilepsy syndrome	0.00272	0.00331	CcSEcCtD
Oxandrolone—Erectile dysfunction—Pregabalin—epilepsy syndrome	0.00271	0.00329	CcSEcCtD
Oxandrolone—Oedema—Felbamate—epilepsy syndrome	0.00269	0.00328	CcSEcCtD
Oxandrolone—AR—Androgen receptor signaling pathway—UBE3A—epilepsy syndrome	0.00266	0.0174	CbGpPWpGaD
Oxandrolone—Oedema—Zonisamide—epilepsy syndrome	0.00264	0.00321	CcSEcCtD
Oxandrolone—Insomnia—Fosphenytoin—epilepsy syndrome	0.00262	0.00319	CcSEcCtD
Oxandrolone—AR—Androgen receptor signaling pathway—FLNA—epilepsy syndrome	0.00262	0.0172	CbGpPWpGaD
Oxandrolone—Haemoglobin—Valproic Acid—epilepsy syndrome	0.00262	0.00318	CcSEcCtD
Oxandrolone—Haemorrhage—Valproic Acid—epilepsy syndrome	0.0026	0.00317	CcSEcCtD
Oxandrolone—Insomnia—Vigabatrin—epilepsy syndrome	0.00256	0.00311	CcSEcCtD
Oxandrolone—Oedema—Clonazepam—epilepsy syndrome	0.00254	0.00309	CcSEcCtD
Oxandrolone—Insomnia—Diazepam—epilepsy syndrome	0.00252	0.00306	CcSEcCtD
Oxandrolone—Irritability—Topiramate—epilepsy syndrome	0.0025	0.00305	CcSEcCtD
Oxandrolone—Erectile dysfunction—Gabapentin—epilepsy syndrome	0.00248	0.00302	CcSEcCtD
Oxandrolone—Blood creatinine increased—Topiramate—epilepsy syndrome	0.00246	0.00299	CcSEcCtD
Oxandrolone—Insomnia—Felbamate—epilepsy syndrome	0.00243	0.00296	CcSEcCtD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TCF4—epilepsy syndrome	0.00242	0.0159	CbGpPWpGaD
Oxandrolone—Oedema—Carbamazepine—epilepsy syndrome	0.00241	0.00293	CcSEcCtD
Oxandrolone—Insomnia—Zonisamide—epilepsy syndrome	0.00238	0.0029	CcSEcCtD
Oxandrolone—AR—Nuclear Receptors—VDR—epilepsy syndrome	0.00238	0.0156	CbGpPWpGaD
Oxandrolone—Haemoglobin—Pregabalin—epilepsy syndrome	0.00237	0.00288	CcSEcCtD
Oxandrolone—Haemorrhage—Pregabalin—epilepsy syndrome	0.00235	0.00286	CcSEcCtD
Oxandrolone—Oedema—Lamotrigine—epilepsy syndrome	0.00233	0.00283	CcSEcCtD
Oxandrolone—Insomnia—Clonazepam—epilepsy syndrome	0.0023	0.0028	CcSEcCtD
Oxandrolone—AR—Coregulation of Androgen receptor activity—PTK2B—epilepsy syndrome	0.00228	0.015	CbGpPWpGaD
Oxandrolone—Insomnia—Phenytoin—epilepsy syndrome	0.00228	0.00278	CcSEcCtD
Oxandrolone—Insomnia—Oxcarbazepine—epilepsy syndrome	0.00227	0.00276	CcSEcCtD
Oxandrolone—Insomnia—Carbamazepine—epilepsy syndrome	0.00218	0.00265	CcSEcCtD
Oxandrolone—Haemorrhage—Gabapentin—epilepsy syndrome	0.00216	0.00263	CcSEcCtD
Oxandrolone—AR—SIDS Susceptibility Pathways—RET—epilepsy syndrome	0.00215	0.0141	CbGpPWpGaD
Oxandrolone—AR—Nuclear Receptors—NR3C1—epilepsy syndrome	0.00214	0.014	CbGpPWpGaD
Oxandrolone—Insomnia—Lamotrigine—epilepsy syndrome	0.0021	0.00256	CcSEcCtD
Oxandrolone—AR—SIDS Susceptibility Pathways—MAP2—epilepsy syndrome	0.00209	0.0137	CbGpPWpGaD
Oxandrolone—Erectile dysfunction—Topiramate—epilepsy syndrome	0.00209	0.00254	CcSEcCtD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—NTF3—epilepsy syndrome	0.002	0.0131	CbGpPWpGaD
Oxandrolone—AR—Notch-mediated HES/HEY network—HES1—epilepsy syndrome	0.00196	0.0129	CbGpPWpGaD
Oxandrolone—AR—Nongenotropic Androgen signaling—FOS—epilepsy syndrome	0.00193	0.0126	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—GABRA1—epilepsy syndrome	0.00191	0.0126	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—SSTR1—epilepsy syndrome	0.00191	0.0126	CbGpPWpGaD
Oxandrolone—AR—Nuclear Receptor transcription pathway—VDR—epilepsy syndrome	0.00188	0.0123	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—CAPN1—epilepsy syndrome	0.00188	0.0123	CbGpPWpGaD
Oxandrolone—Oedema—Valproic Acid—epilepsy syndrome	0.00185	0.00225	CcSEcCtD
Oxandrolone—AR—Regulation of Androgen receptor activity—SIRT1—epilepsy syndrome	0.00185	0.0121	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—SSTR2—epilepsy syndrome	0.00184	0.0121	CbGpPWpGaD
Oxandrolone—Haemoglobin—Topiramate—epilepsy syndrome	0.00182	0.00222	CcSEcCtD
Oxandrolone—Haemorrhage—Topiramate—epilepsy syndrome	0.00182	0.00221	CcSEcCtD
Oxandrolone—Testosterone—SLCO1A2—epilepsy syndrome	0.0018	0.0695	CrCbGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—CHRNA7—epilepsy syndrome	0.00178	0.0117	CbGpPWpGaD
Oxandrolone—AR—Nuclear Receptor transcription pathway—NR3C1—epilepsy syndrome	0.00169	0.0111	CbGpPWpGaD
Oxandrolone—Spironolactone—ABCC2—epilepsy syndrome	0.00168	0.065	CrCbGaD
Oxandrolone—Insomnia—Valproic Acid—epilepsy syndrome	0.00167	0.00204	CcSEcCtD
Oxandrolone—Oedema—Pregabalin—epilepsy syndrome	0.00167	0.00203	CcSEcCtD
Oxandrolone—AR—Regulation of Androgen receptor activity—NR3C1—epilepsy syndrome	0.00164	0.0108	CbGpPWpGaD
Oxandrolone—AR—Notch-mediated HES/HEY network—KDR—epilepsy syndrome	0.00157	0.0103	CbGpPWpGaD
Oxandrolone—Testosterone—CYP11A1—epilepsy syndrome	0.00157	0.0605	CrCbGaD
Oxandrolone—Oedema—Gabapentin—epilepsy syndrome	0.00153	0.00187	CcSEcCtD
Oxandrolone—Insomnia—Pregabalin—epilepsy syndrome	0.00151	0.00184	CcSEcCtD
Oxandrolone—AR—SIDS Susceptibility Pathways—SLC1A3—epilepsy syndrome	0.00151	0.00993	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—AQP4—epilepsy syndrome	0.00151	0.00993	CbGpPWpGaD
Oxandrolone—AR—FOXA1 transcription factor network—FOS—epilepsy syndrome	0.00145	0.00955	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—CHRM2—epilepsy syndrome	0.00142	0.00933	CbGpPWpGaD
Oxandrolone—Fluoxymesterone—NR3C1—epilepsy syndrome	0.0014	0.0541	CrCbGaD
Oxandrolone—Insomnia—Gabapentin—epilepsy syndrome	0.00139	0.00169	CcSEcCtD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—VDR—epilepsy syndrome	0.0013	0.00851	CbGpPWpGaD
Oxandrolone—Oedema—Topiramate—epilepsy syndrome	0.00129	0.00157	CcSEcCtD
Oxandrolone—AR—Androgen receptor signaling pathway—CDC42—epilepsy syndrome	0.00129	0.00844	CbGpPWpGaD
Oxandrolone—Spironolactone—NR3C1—epilepsy syndrome	0.00128	0.0495	CrCbGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—CHRNB2—epilepsy syndrome	0.00128	0.00838	CbGpPWpGaD
Oxandrolone—AR—Nongenotropic Androgen signaling—SRC—epilepsy syndrome	0.00124	0.00814	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—MEF2C—epilepsy syndrome	0.00123	0.00806	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—SIRT1—epilepsy syndrome	0.00122	0.00801	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—EIF2AK2—epilepsy syndrome	0.00121	0.00794	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—JUND—epilepsy syndrome	0.00121	0.00794	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—YWHAZ—epilepsy syndrome	0.0012	0.00786	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—NR3C1—epilepsy syndrome	0.00117	0.00766	CbGpPWpGaD
Oxandrolone—Insomnia—Topiramate—epilepsy syndrome	0.00117	0.00142	CcSEcCtD
Oxandrolone—AR—SIDS Susceptibility Pathways—CHRNA4—epilepsy syndrome	0.00116	0.00761	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—TSC1—epilepsy syndrome	0.00111	0.00726	CbGpPWpGaD
Oxandrolone—AR—Coregulation of Androgen receptor activity—CASP8—epilepsy syndrome	0.00109	0.00719	CbGpPWpGaD
Oxandrolone—Norethindrone—CYP2C19—epilepsy syndrome	0.00109	0.0419	CrCbGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—SLC6A4—epilepsy syndrome	0.00108	0.00707	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—SST—epilepsy syndrome	0.00105	0.00688	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—NTRK2—epilepsy syndrome	0.00105	0.00688	CbGpPWpGaD
Oxandrolone—AR—FOXA1 transcription factor network—JUN—epilepsy syndrome	0.00104	0.00686	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—IL1RN—epilepsy syndrome	0.00104	0.00685	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—TH—epilepsy syndrome	0.00096	0.0063	CbGpPWpGaD
Oxandrolone—AR—Regulation of Androgen receptor activity—JUN—epilepsy syndrome	0.0009	0.00591	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—FOS—epilepsy syndrome	0.000893	0.00586	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—CDC42—epilepsy syndrome	0.000842	0.00553	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—JUNB—epilepsy syndrome	0.000822	0.0054	CbGpPWpGaD
Oxandrolone—AR—Regulation of Androgen receptor activity—SRC—epilepsy syndrome	0.000807	0.0053	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—SIRT1—epilepsy syndrome	0.000799	0.00525	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—AVP—epilepsy syndrome	0.000794	0.00521	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—BDNF—epilepsy syndrome	0.000782	0.00514	CbGpPWpGaD
Oxandrolone—AR—Nongenotropic Androgen signaling—AKT1—epilepsy syndrome	0.000771	0.00506	CbGpPWpGaD
Oxandrolone—Testosterone—ABCG2—epilepsy syndrome	0.000761	0.0294	CrCbGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—HES1—epilepsy syndrome	0.000751	0.00493	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—WARS—epilepsy syndrome	0.000741	0.00486	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—MEF2C—epilepsy syndrome	0.000726	0.00477	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—YWHAZ—epilepsy syndrome	0.000702	0.00461	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—NGF—epilepsy syndrome	0.000694	0.00456	CbGpPWpGaD
Oxandrolone—Progesterone—NR3C1—epilepsy syndrome	0.000694	0.0268	CrCbGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—NR3C1—epilepsy syndrome	0.000691	0.00454	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—RELA—epilepsy syndrome	0.000679	0.00446	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—BDNF—epilepsy syndrome	0.000665	0.00437	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—SIRT1—epilepsy syndrome	0.000662	0.00435	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—HTR2A—epilepsy syndrome	0.000661	0.00434	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—ABCB1—epilepsy syndrome	0.000654	0.0043	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—JUN—epilepsy syndrome	0.000648	0.00425	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—TSC2—epilepsy syndrome	0.000644	0.00423	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—JUN—epilepsy syndrome	0.000641	0.00421	CbGpPWpGaD
Oxandrolone—Progesterone—CYP2C19—epilepsy syndrome	0.000633	0.0244	CrCbGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—epilepsy syndrome	0.00063	0.00414	CbGpPWpGaD
Oxandrolone—Spironolactone—ABCB1—epilepsy syndrome	0.000619	0.0239	CrCbGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—ATM—epilepsy syndrome	0.000607	0.00399	CbGpPWpGaD
Oxandrolone—Norethindrone—ALB—epilepsy syndrome	0.000602	0.0233	CrCbGaD
Oxandrolone—Testosterone—CYP2C19—epilepsy syndrome	0.000598	0.0231	CrCbGaD
Oxandrolone—AR—Androgen receptor signaling pathway—JUN—epilepsy syndrome	0.000595	0.0039	CbGpPWpGaD
Oxandrolone—Norethindrone—ABCB1—epilepsy syndrome	0.000575	0.0222	CrCbGaD
Oxandrolone—Methyltestosterone—ALB—epilepsy syndrome	0.000572	0.0221	CrCbGaD
Oxandrolone—AR—Gene Expression—QARS—epilepsy syndrome	0.000561	0.00369	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—SRC—epilepsy syndrome	0.000533	0.0035	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—CASP8—epilepsy syndrome	0.00053	0.00348	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—ATM—epilepsy syndrome	0.000503	0.0033	CbGpPWpGaD
Oxandrolone—Progesterone—CYP2D6—epilepsy syndrome	0.000469	0.0181	CrCbGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—BCL2—epilepsy syndrome	0.000455	0.00299	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—EIF2B5—epilepsy syndrome	0.000449	0.00295	CbGpPWpGaD
Oxandrolone—AR—Coregulation of Androgen receptor activity—AKT1—epilepsy syndrome	0.000448	0.00294	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	0.000439	0.00288	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—MTOR—epilepsy syndrome	0.000436	0.00286	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—JUNB—epilepsy syndrome	0.000409	0.00268	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—TFAM—epilepsy syndrome	0.000406	0.00266	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—CASP3—epilepsy syndrome	0.000401	0.00263	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	0.000397	0.00261	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—IL1B—epilepsy syndrome	0.000392	0.00257	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—CASP3—epilepsy syndrome	0.000391	0.00257	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—JUN—epilepsy syndrome	0.00039	0.00256	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—JUN—epilepsy syndrome	0.00038	0.00249	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	0.000377	0.00247	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	0.000358	0.00235	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—epilepsy syndrome	0.000357	0.00235	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—SNRPE—epilepsy syndrome	0.00035	0.0023	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—VEGFA—epilepsy syndrome	0.00034	0.00223	CbGpPWpGaD
Oxandrolone—Progesterone—ABCB1—epilepsy syndrome	0.000335	0.0129	CrCbGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	0.000332	0.00218	CbGpPWpGaD
Oxandrolone—Testosterone—ALB—epilepsy syndrome	0.000332	0.0128	CrCbGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—VEGFA—epilepsy syndrome	0.000332	0.00218	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—AKT1—epilepsy syndrome	0.000331	0.00218	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—VDR—epilepsy syndrome	0.000324	0.00213	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	0.000323	0.00212	CbGpPWpGaD
Oxandrolone—Testosterone—ABCB1—epilepsy syndrome	0.000317	0.0122	CrCbGaD
Oxandrolone—AR—Generic Transcription Pathway—NR3C1—epilepsy syndrome	0.000292	0.00192	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	0.00029	0.0019	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—TNF—epilepsy syndrome	0.000284	0.00187	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	0.000282	0.00185	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—EIF2S1—epilepsy syndrome	0.000244	0.0016	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	0.000242	0.00159	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—HSPB1—epilepsy syndrome	0.000236	0.00155	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—AKT1—epilepsy syndrome	0.000217	0.00143	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—JUNB—epilepsy syndrome	0.000197	0.00129	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	0.00018	0.00118	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—SIRT1—epilepsy syndrome	0.000158	0.00104	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—VDR—epilepsy syndrome	0.000156	0.00103	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—H2AFX—epilepsy syndrome	0.000148	0.000972	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—YWHAZ—epilepsy syndrome	0.000143	0.000938	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—NR3C1—epilepsy syndrome	0.000141	0.000923	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—AKT1—epilepsy syndrome	4.3e-05	0.000283	CbGpPWpGaD
